Kelly Curtin-hallinan, DO | |
2003 E Market St, York, PA 17402-2841 | |
(717) 812-4242 | |
(717) 755-7569 |
Full Name | Kelly Curtin-hallinan |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 2003 E Market St, York, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114184736 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | OS015470 (Pennsylvania) | Primary |
Entity Name | Wellspan Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.
International Day of Radiology — November 8, 2012 — marks the 117th anniversary of the discovery of the X-ray and the tremendous advances in patient care made possible by radiation therapy and medical imaging exams, such as MRI and CT scans. It is also a reminder that Congress needs to pass the Diagnostic Imaging Services Access Protection Act (H.R. 3269/ S. 2347) and halt drastic cuts in Medicare funding for imaging scans. This vital legislation would preserve ready access to lifesaving imaging care and may help reduce harm to seniors already resulting from cutbacks.
Early life stress encodes lifelong susceptibility to stress through long-lasting transcriptional programming in a brain reward region implicated in mood and depression, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published June 15 in the journal Science.
New data show patients with chronic low back pain on Cymbalta(R) (duloxetine HCl) maintained reductions in pain for 41 weeks. In patients who initially responded to duloxetine, this maintenance of pain reduction was accompanied by further reduction in pain that was statistically significant as measured by the Brief Pain Inventory (BPI) average pain rating.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Kelly Curtin-hallinan, DO 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 812-4242 | Kelly Curtin-hallinan, DO 2003 E Market St, York, PA 17402-2841 Ph: (717) 812-4242 |
News Archive
BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.
International Day of Radiology — November 8, 2012 — marks the 117th anniversary of the discovery of the X-ray and the tremendous advances in patient care made possible by radiation therapy and medical imaging exams, such as MRI and CT scans. It is also a reminder that Congress needs to pass the Diagnostic Imaging Services Access Protection Act (H.R. 3269/ S. 2347) and halt drastic cuts in Medicare funding for imaging scans. This vital legislation would preserve ready access to lifesaving imaging care and may help reduce harm to seniors already resulting from cutbacks.
Early life stress encodes lifelong susceptibility to stress through long-lasting transcriptional programming in a brain reward region implicated in mood and depression, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published June 15 in the journal Science.
New data show patients with chronic low back pain on Cymbalta(R) (duloxetine HCl) maintained reductions in pain for 41 weeks. In patients who initially responded to duloxetine, this maintenance of pain reduction was accompanied by further reduction in pain that was statistically significant as measured by the Brief Pain Inventory (BPI) average pain rating.
› Verified 5 days ago
Dr. Yvette Yamcek-meleka, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2339 S George St, York, PA 17403 Phone: 717-812-3040 Fax: 717-812-3049 | |
Dr. Furman Titus Updike Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2062 Wyntre Brooke Dr, York, PA 17403 Phone: 717-815-0505 | |
Samira Kannarkatt, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2050 S Queen St Ste 100, York, PA 17403 Phone: 717-812-4240 Fax: 717-848-5520 | |
Dr. Sheela Moorthy, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1001 S George St, York, PA 17403 Phone: 717-851-2613 Fax: 717-851-2602 | |
Alexa Laudenslager, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2675 Joppa Rd, York, PA 17403 Phone: 717-741-9063 Fax: 717-718-9779 | |
Dr. Pamela Faith Mccarter, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 605 S George St, Ste 200, York, PA 17401 Phone: 717-851-2334 Fax: 717-851-3498 |